 |
4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl) |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic Functional Vomiting to include functional vomiting and cyclic vomiting syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2006-10-11 00:00:00 |
| Sponsor | Dynogen Pharmaceuticals, Inc.;52 Second Avenue;Waltham, Massachusetts, 02451 |
